Company Active LTD

Company profile

Ideabatic LTD.

SMILE SMart Last-mILE Cooling System; Last-mile cold-chain | IDEABATIC

IDEABATIC's SMILE is designed to solve cold-chain and user errors in vaccination and sample collection and delivery, including for COVID-19. SMILE helps preserve temperature-sensitive products and ensures critical research is uninterrupted.

CRN
10121038
Founded
2016
Age
10

Overview

Legal name
IDEABATIC LTD.
Region
East of England
Registered address
C/O TC THOMPSON TARAZ RAND SUITE 20 NEW CAMBRIDGE HOUSE
BASSINGOURNE ROAD
LITLINGTON
CAMBRIDGESHIRE
ENGLAND
SG8 0SS
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

6 events
26 Apr
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

12 Apr
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

28 Mar
2026

Change To A Person With Significant Control

Persons-with-significant-control

PSC04 | Transaction MzUxMzA2MTIwM2FkaXF6a2N4

Published 28 Mar 2026 03:05

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

13 Apr
2016

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2020
Funded years
2020, 2022, 2024
Age at first award
3 years

Projects

2024 Collaborative R&D Lead participant

IDEABATIC - Manufacturing cost reduction in SMILE foam parts

1 May 2024 to 31 Jul 2024

Awarded
£9,998
Total cost £9,998

This project proposed by Ideabatic aims to enhance the production efficiency of its innovative SMILE (SMart last-MILE) vaccine cooling system. After a successful pilot in Cameroon, during which SMILE surpassed existing solutions by lasting four days, the Ministry of Health in Cameroon has indicated a requirement for the implementation of 2700 units. This ...

2022 Collaborative R&D Lead participant

Feasibility studies of SMILE (SMart Last-mILE cooling system) for the developed world

1 Jan 2022 to 31 Mar 2022

Awarded
£18,953
Total cost £27,076

According to the WHO, pre-COVID-19, 20 million children worldwide still had no access to basic vaccinations and 2 to 3 million children died each year of a vaccine-preventable disease. Globally, 20-50% of vaccines are wasted and in remote areas, 85% spoilage has been reported. One of the reasons is that during the last few miles of delivery ('last-mile') ...

2020 Collaborative R&D Lead participant

Measurement and prediction of SMILE vaccine carrier’s behaviour during typical usage

1 Apr 2020 to 30 Apr 2021

Awarded
£14,648
Total cost £14,648

According to the WHO, currently 19 million children still lack basic vaccinations. Each year, two to three million children die of a vaccine-preventable disease. A major reason for this is that vaccines are damaged by fluctuations in temperature. That is, they become too hot or too cold. Frequently, outreach vaccine delivery journeys can take up to seven ...

Product types

Collaborative R&D